Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 826-837

  Koshy, Mary ^a   Berger, Douglas ^a   Crow, Mary K ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

autoimmunity; CD40 ligand; lupus erythematosus; lymphocyte activation; systemic; T lymphocytes

Indexed keywords

AUTOANTIBODY; CD40 ANTIGEN; LIGAND; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0029862164     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118855     Document Type: Article

References (57)

1. Hardin, J.A. 1986. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 29:457-460.
2. Gharavi, A., J.L. Chu, and K.B. Elkon. 1988. Autoantibodies in systemic lupus erythematosus are not due to random polyclonal B cell activation. Arthritis Rheum. 31:1337-1345.
3. Mohan, C., S. Adams, V. Stanik, and S.K. Datta. 1993. Nucleosome. A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367-1381.
4. Burlingame, R.W., M.L. Boey, G. Starkebaum, and R.L. Rubin. 1994. The central role of chromatin in autoimmune responses to histones and DNA in SLE. J. Clin. Invest. 94:184-192.
5. Radic, M.Z., and M. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12:487-520.
6. Pham, B., N.L. Prin, D. Gosset, P.Y. Hatron, B. Devulder, A. Capron, and J.P. Dessaint. 1989. T lymphocyte activation in systemic lupus erythematosus analyzed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots. Clin. Exp. Immunol. 77:168-174.
7. Hoffman, R.W., Y. Takeda, G.C. Sharp, D.R. Lee, D.L. Hill, H. Kaneoka and C.W. Caldwell. 1993. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J. Immunol. 151:6460-6467.
8. Okubo, M., K. Yamamoto, T. Kato, N. Matsuura, T. Nishimaki, R. Kasukawa, K. Ito, Y. Mizushima, and K. Nishioka. 1993. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. J. Immunol. 151:1108-1115.
9. O'Brien, R.M., D.S. Cram, R.L. Coppel, and L.C. Harrison. 1990. T-cell epitopes on the 70-kDa protein of the (U1)RNP complex in autoimmune rheumatologic disorders. J. Autoimmun. 3:747-757.
10. Crow, M.K., G. DelGiudice-Asch, J.B. Zehetbauer, J.L. Lawson, N. Brot, H. Weissbach, and K.B. Elkon. 1994. Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. J. Clin. Invest. 94:345-352.
11. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science (Wash. DC). 169:1042-1049.
12. Bretscher, P. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today. 13:74-76.
13. Lederman, S., M.J. Yellin, A. Krichevsky, J. Belko, J.J. Lee, and L. Chess. 1992. Identification of a novel surface protein on activated CD4+ T cells that induces contact dependent B cell differentiation. J. Exp. Med. 175:1091-1101.
14. Hollenbaugh, D., I. Grosmire, C. Kullas, N. Chalupny, S. Braesch-Andersen, R. Noelle, I. Stamenkovic, J. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell costimulatory activity. EMBO (Eur. Mol. Biol. Organ.) J. 11:4314-4321.
15. Spriggs, M.K., R.J. Armitage, L. Strockbine, K.N. Clifford, B.M. Macduff, T.A. Sato, C.R. Maliszewski, and W.C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543-1550.
16. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Ann Rev. Immunol. 12:881-922.
17. Lederman, S., M.J. Yellin, G. Inghirami, J.J. Lee, D.M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of T-B activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149:3817-3826.
18. Shapira, S.K., D. Vercelli, H.H. Jabara, S.M. Fu, and R.S. Geha. 1992. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175:289-292.
19. Splawski, J.B., S.M. Fu, and P.E. Lipsky. 1993. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150:1276-1285.
20. Grabstein, K.H., C.R. Maliszewski, K. Shanebeck, T.A. Sato, M.K. Spriggs, W.C. Fanslow, and R.J. Armitage. 1993. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J. Immunol. 150: 3141-3147.
21. Nonoyama, S., D. Hollenbaugh, A. Aruffo, J.A. Ledbetter, and H.D. Ochs. 1993. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J. Exp. Med. 178:1097-1102.
22. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, W.C. Fanslow, J.W. Belmont, and M.K. Spriggs. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (Wash. DC). 259: 990-993.
23. Korthauer, U., D. Graf, H.W. Mages, F. Briere, M. Padayachee, S. Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:539-541.
24. DeSanto, J.P., Y.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:542-543.
25. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, S. Grosmaire, R. Stenkamp, M. Neubauer, R.L. Roberts, R.J. Noelle, J.A. Ledbetter, U. Francke, and H.D. Ochs. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:292-300.
26. Ramesh, N., R. Fuleihan, V. Ramesh, S. Lederman, M.J. Yellin, S. Sharma, L. Chess, F.S. Rosen, and R.S. Geha. 1993. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int. Immunol. 5:769-773.
27. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, F.S. Rosen, T. Chatila, S.M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2173.
28. Conley, M.E., M. Larche, V.R. Bonagura, A.R. Lawton III, R.H. Buckley, S.M. Fu, E. Coustan-Smith, H.G. Herrod, and D. Campana. 1994. Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J. Clin. Invest. 94:1404-1409.
29. Barrett, T.B., G. Shu, and E.A. Clark. 1991. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1722-1729.
30. Saeland, S., V. Duvert, I. Moreau, and J. Banchereau. 1993. Human B cell precursors proliferate and express CD23 after CD40 ligation. J. Exp. Med. 178:113-120.
31. Yellin, M.J., J. Sinning, L.R. Covey, W. Sherman, J.J. Lee, E. Glickman-Nir, K.C. Sippel, J. Rogers, A.M. Cleary, M. Parker, L. Chess, and S. Lederman. 1994. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J. Immunol. 153:666-674.
32. Schattner, E., K.B. Elkon, J. Tumang, M.K. Crow, and S.M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182: 1557-1565.
33. Boussiotis, V.A., L.M. Nadler, J.L. Strominger, and A.E. Goldfeld. 1994. Tumor necrosis factor α is an autocrine growth factor for normal human B cells. Proc. Natl. Acad. Sci. 91:7007-7011.
34. Renshaw, B.R., B.R. Fanslow, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
35. Castigli, E., F.A. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A. Bhan, and R.S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA. 91:12135-12139.
36. Lederman, S., M.J. Yellin, A.M. Cleary, A. Pernis, G. Inghirami, L.E. Cohn, L.R. Covey, J.J. Lee, P. Rothman, and L. Chess. 1994. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 152:2163-2171.
37. Roy, M., T. Waldschmidt, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151:2497-2510.
38. Fuleihan, R., N. Ramesh, A. Horner, D. Ahern, P.J. Belshaw, D.G. Alberg, I. Stamenkovic, W. Harmon, and R.S. Geha. 1994. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 93:1315-1320.
39. Yellin, M.J., K. Sippel, G. Inghirami, L.R. Covey, J.J. Lee, J. Sinning, E.A. Clark, L. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/ CD40-L. J. Immunol. 152:598-608.
40. Tan, E.M., A.S. Cohen, J.P. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, J.G. Schaller, N. Talal, and R.J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
41. Glinski, W., D.R. Gershwin, D.R. Budman, and A.D. Steinberg. 1976. Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient. Clin. Exp. Immunol. 26:228-238.
42. Veda, Y., T. Sakane, and T. Tsunematsu. 1989. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus. J. Immunol. 143:3988-3983.
43. Krishnan, C., and M.H. Kaplan. 1967. Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gammaglobulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J. Clin. Invest. 46:569-579.
44. Lehmann, P.V., T. Forsthuber, A. Miller, and E.E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (Lond.). 358:155-157.
45. Fatenjad, S., W. Brooks, A. Schwartz, and J. Craft. 1994. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. J. Immunol. 152:5523-5531.
46. Topfer, F., T. Gordon, and J. McCluskey. 1995. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc. Natl. Acad. Sci. USA. 92:875-879.
47. James, J.A., T. Gross, R.H. Scofield, and J.B. Harley. 1995. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J. Exp. Med. 181:453-461.
48. Casamayor-Palleja, M., M. Khan, I.C. MacKennan. 1995. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after ligation through the T cell receptor complex. J. Exp. Med. 181:1293-1301.
49. Grammer, A.C., M.C. Bergman, Y. Miura, K. Fujita, L.S. Davis, and P.E. Lipsky. 1995. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154:4996-5010.
50. Crow, M.K., J.A. Jover, and S.M. Friedman. 1986. Direct T helper-B cell interactions induce an early B cell activation antigen. J. Exp. Med. 164:1760-1772.
51. Jover, J.A., E.K. Chartash, B. Kushner, S.M. Friedman, and M.K. Crow. 1989. T helper cell-indueed CD23 (BLAST-2) expression: An activation marker for the high density fraction of human B cells. Clin. Immunol. Immunopathol. 53:99-112.
52. Crow, M.K., B. Kushner, J.A. Jover, S.M. Friedman, S.E. Mechanic, and W. Stohl. 1989. Human peripheral blood T helper cell-induced B cell activation results in B cell surface expression of the CD23 (BLAST-2) antigen. Cell Immunol. 121:99-112.
53. Tumang, J.R., D.N. Posnett, B.C. Cole, M.K. Crow, and S.M. Friedman. 1990. Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. J. Exp. Med. 171:2153-2158.
54. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R. Hoelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596-603.
55. Matzinger, P. 1994. Tolerance, danger, and extended family. Annu. Rev. Immunol. 12:991-1045.
56. Durie, F.H., A. Aruffo, J. Ledbetter, K.M. Crassi, W.R. Green, and L.D. Fast. 1994. Antibody to ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1333-1338.
57. Mohan, C., Y. Shi, J.D. Laman, and S.K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470-1480.